Epixis
Paris
About Epixis
Epixis SA, a biotechnology company, engages in the development of advanced immuno-therapies based on recombinant virus-like particles against hepatitis C. The company was founded in 2003 and is based in Paris, France.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Funding stage: M&A
- Last round: Non-Equity Assistance (Jan 2004)
- Website: epixis.com
- Phone: 33 1 42 17 65 20
Industries & Categories
Biotechnology, Health Care
Canonical: https://fsome.com/organization/epixis-2058612 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.